Introduction
Bacterial endotoxin is a principal component of the Gram-negative bacterial cell wall and is an important mediator in sepsis because of its capacity to stimulate the production of macrophage tumour necrosis factor (TNF). Antimicrobial agents have been reported to influence the inflammatory response. Clindamycin and netilmicin have been shown to markedly inhibit neutrophil phagocytosis and superoxide production 1 and ketoconazole has been reported to inhibit alveolar macrophage leukotriene and procoagulant activity. 2 Dofferhoff et al. showed that selected antimicrobial agents such as ketoconazole affected the release of free endotoxin from killed bacteria both in vitro and in vivo 3 and oral cephalosporins have been shown to inhibit macrophage TNF and interleukin-6 activity. 4 Using the filtrates of bacteria killed by ciprofloxacin, Simon et al. 5 showed that each compound affected the release of TNF from the monocyte THP-1 cell line differently and suggested that antibiotics may modulate the inflammatory response in addition to their antibacterial activity. We therefore undertook a study to ascertain whether antibiotics altered the macrophage TNF response to endotoxin stimulation in vitro.
Materials and methods
All experiments are performed according to guidelines of the Institutional Review Board and Animal Care Committee of the University of Texas Southwestern Medical Center at Dallas for the care and handling of the animals in accordance with recommendations of the National Institutes of Health.
Alveolar macrophages
Alveolar macrophages were obtained by lavage of the intact tracheobronchial tree with isotonic saline solution of New Zealand white rabbits after they had been killed by injecting nembutal 1 mL/kg. The cell suspensions were examined by differential staining to ensure homogeneity and any containing less than 95% macrophages were discarded. Cell viability was determined by Trypan Blue dye exclusion of 98%. agent each with a different mechanism of action; pharmaceutical preparations were used.
Antimicrobial agents

Bacterial preparation
Pseudomonas aeruginosa ATCC 27853 was inoculated on to Tryptic Soy Agar plates (Sigma Chemicals, St Louis, MO, USA) supplemented with 5% sheep blood and incubated at 38°C for 24 h. Inocula were prepared by suspending bacteria in sufficient phosphate-buffered saline to yield densities of 10 5 , 10 6 and 10 7 cfu/mL as determined by absorbance at 540 nm. , 10 5 or 10 6 cfu/mL. After 24 h incubation at 37°C in air enriched with 5% CO 2 , the plates were centrifuged at 15,000 g and supernatants were removed and stored at -70°C until assayed for TNF.
Treatment of macrophages
Tumour necrosis factor assay
TNF activity was measured using a cytolytic assay with actinomycin D-treated L929 cells (American Type Culture Collection) and cultured in 96-well microtitration plates with 5 L of either purified recombinant human TNF (Cellular Products Inc., Buffalo, NY, USA) or the supernatants collected from the macrophage suspensions. Standard curves were generated in triplicate, and samples to be tested were added to wells in triplicate at three different dilutions. The results were expressed as units/mL.
Statistical analyses
The data are presented as the mean together with its standard error; group means were compared using analysis of variance with the level of significance being set to P < 0.05.
Results
The maximum TNF activity was seen after alveolar macrophages had been incubated with 1.0 mg/L LPS without antibiotics (i.e. controls) (Figure 1 ) whereas the peak dose response for macrophages exposed to the antimicrobial agents occurred after stimulation with 0.1 mg/L LPS. However, there was no statistically significant difference in LPS-induced TNF activity between the macrophages exposed to the different antimicrobial agents.
Macrophages that had been stimulated by 10 4 cfu/mL live P. aeruginosa but exposed to saline produced significantly more TNF than did the macrophages exposed to antimicrobial agents (P < 0.002) (Figure 2) . TNF production was significantly less for macrophages exposed to ciprofloxacin than for cells exposed to aztreonam (P < 0.008), ceftazidime (P < 0.002) or imipenem (P < 0.019); this effect was also seen after stimulation with 10 5 cfu/mL or 10 6 cfu/mL live P. aeruginosa. After stimulation by 10 6 cfu/mL live P. aeruginosa, TNF activity was significantly higher after exposure to aztreonam, ceftazidime or imipenem than after exposure to either ciprofloxacin or amikacin.
Discussion
In an attempt to differentiate between direct antimicrobial effects on macrophage TNF release, and effects based on bacterial killing, we stimulated macrophages with known amounts of endotoxin and also with live bacteria but found that the latter induced greater TNF activity than did purified LPS. Moreover, stimulating the macrophages with live P. aeruginosa resulted in significantly higher TNF activity when the cells were exposed to -lactam antibiotics than when they were exposed to amikacin or ciprofloxacin, which might be explained by the bacteriostatic or bactericidal mechanisms by which these agents produce their effects. -Lactam antibiotics affect cell wall synthesis by binding to the penicillin-binding proteins, PBP-1, PBP-2 and PBP-3, and might cause the release of greater amounts of LPS by allowing bacterial cells to grow to a larger size before lysis. 6 This is supported by the observations of Jackson & Kropp 7 who showed that 10-to 40-fold more LPS was released from P. aeruginosa after exposure to ceftazidime, which induces filamentation and therefore an increase in cell mass, than was found after exposing the bacteria to imipenem, which does not. 7 In contrast, amikacin, which interferes with bacterial protein synthesis, and ciprofloxacin, which inhibits DNA gyrase, both depressed TNF production which might be explained either by the cells remaining small due to arrested growth or by the inhibition of the synthesis of the large amounts of LPS necessary for intense macrophage stimulation. Although we did not determine the exact amount of endotoxin released by the live bacteria, we did observe that macrophages exposed to ceftazidime, aztreonam or imipenem produced more TNF after stimulation by 10 6 cfu/mL P. aeruginosa than was found after stimulation of these cells by 0.1 mg/L or 1.0 mg/L LPS under the same conditions. Whatever the explanation, these data suggest that different classes of antimicrobial agent are capable of modulating TNF production differently which may be translated into differences in the inflammatory response seen in infections caused by Gram-negative bacilli. Figure 2 . TNF response of alveolar macrophages to live P. aeruginosa in the presence of either saline (control) or five different antimicrobial agents ( , amikacin; , aztreonam; , ciprofloxacin; , ceptaidime; , imipenem; , saline) (mean values ± standard error of the mean). Macrophages exposed to ciprofloxacin (*) and amikacin ( ) produced significantly less TNF at 10 6 cfu/mL P. aeruginosa than did those exposed to saline (#), ceftazidime, imipenem and aztreonam (P < 0.05). TNF activity was also significantly less at each density of live P. aeruginosa.
